335 related articles for article (PubMed ID: 33213216)
21. Validated medication deprescribing instruments for patients with palliative care needs: a systematic review.
de Andrade FK; Nunes RPI; Zanetti MOB; Zanetti ACB; Dos Santos M; de Oliveira AM; Carson-Stevens A; Pereira LRL; Varallo FR
Farm Hosp; 2024; 48(2):83-89. PubMed ID: 37770284
[TBL] [Abstract][Full Text] [Related]
22. Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria.
Curtin D; Jennings E; Daunt R; Curtin S; Randles M; Gallagher P; O'Mahony D
J Am Geriatr Soc; 2020 Apr; 68(4):762-769. PubMed ID: 31868920
[TBL] [Abstract][Full Text] [Related]
23. The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy.
Kaminaga M; Komagamine J; Tatsumi S
Sci Rep; 2021 Apr; 11(1):8898. PubMed ID: 33903645
[TBL] [Abstract][Full Text] [Related]
24. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
Palagyi A; Keay L; Harper J; Potter J; Lindley RI
BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
[TBL] [Abstract][Full Text] [Related]
25. Validated medication deprescribing instruments for patients with palliative care needs palliative care: A systematic review.
de Andrade FK; Ignacio Nunes RP; Barboza Zanetti MO; Barboza Zanetti AC; Dos Santos M; de Oliveira AM; Carson-Stevens A; Leira Pereira LR; Rossi Varallo F
Farm Hosp; 2024; 48(2):T83-T89. PubMed ID: 38016841
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
[TBL] [Abstract][Full Text] [Related]
27. Involving older people in decisions about deprescribing in end of life care.
McGraw C
Nurs Stand; 2022 Nov; 37(11):55-60. PubMed ID: 36213960
[TBL] [Abstract][Full Text] [Related]
28. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
Todd A; Jansen J; Colvin J; McLachlan AJ
BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
[TBL] [Abstract][Full Text] [Related]
29. Deprescribing in palliative care.
Thompson J
Clin Med (Lond); 2019 Jul; 19(4):311-314. PubMed ID: 31308110
[TBL] [Abstract][Full Text] [Related]
30. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
Anderson K; Freeman C; Foster M; Scott I
J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
[TBL] [Abstract][Full Text] [Related]
31. Deprescribing: An umbrella review.
Japelj N; Horvat N; Knez L; Kos M
Acta Pharm; 2024 Jun; 74(2):249-267. PubMed ID: 38815201
[TBL] [Abstract][Full Text] [Related]
32. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.
Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S
BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576
[TBL] [Abstract][Full Text] [Related]
33. Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis.
Shrestha S; Poudel A; Cardona M; Steadman KJ; Nissen LM
Ther Adv Drug Saf; 2021; 12():20420986211052343. PubMed ID: 34707802
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
Omuya H; Nickel C; Wilson P; Chewning B
Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
[TBL] [Abstract][Full Text] [Related]
35. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
[TBL] [Abstract][Full Text] [Related]
36. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.
Page AT; Clifford RM; Potter K; Schwartz D; Etherton-Beer CD
Br J Clin Pharmacol; 2016 Sep; 82(3):583-623. PubMed ID: 27077231
[TBL] [Abstract][Full Text] [Related]
37. Appropriate deprescribing in older people: a challenging necessityCommentary to accompany themed collection on deprescribing.
van der Velde N; Minhas JS
Age Ageing; 2021 Sep; 50(5):1516-1519. PubMed ID: 34260681
[TBL] [Abstract][Full Text] [Related]
38. Deprescribing in Older Adults With Cardiovascular Disease.
Krishnaswami A; Steinman MA; Goyal P; Zullo AR; Anderson TS; Birtcher KK; Goodlin SJ; Maurer MS; Alexander KP; Rich MW; Tjia J;
J Am Coll Cardiol; 2019 May; 73(20):2584-2595. PubMed ID: 31118153
[TBL] [Abstract][Full Text] [Related]
39. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
40. Does Deprescribing Improve Quality of Life? A Systematic Review of the Literature.
Pruskowski JA; Springer S; Thorpe CT; Klein-Fedyshin M; Handler SM
Drugs Aging; 2019 Dec; 36(12):1097-1110. PubMed ID: 31598908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
